Implantable Cardioverter-Defibrillator (ICD) Utilization in a Potentially Eligible VA Population
Overview
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Stanford University
- Enrollment
- 89
- Locations
- 2
- Primary Endpoint
- Referral for Implantable Cardioverter Defibrillator
Overview
Brief Summary
Despite being a proven life-saving intervention in appropriately selected individuals, multiple studies continue to demonstrate low implantation of defibrillators in potential candidates. Based upon prior research, a major barrier to low utilization is low referral of potential candidates by healthcare providers. In this study, via brief clinical reminder placed in the electronic medical record, we ask healthcare providers who have not referred potential candidates for defibrillator the reasons for this decision and provide them with the tools for referral if appropriate.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Meeting published criteria for receipt of an implantable cardioverter defibrillator
Exclusion Criteria
- •provider is not affiliated with the VA health care system
Outcomes
Primary Outcomes
Referral for Implantable Cardioverter Defibrillator
Time Frame: 6 months
Referral of the patient to electrophysiology clinic for evaluation for cardioverter defibrillator implantation.
Secondary Outcomes
No secondary outcomes reported
Investigators
Paul A. Heidenreich
Investigator
Stanford University